Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, Accustem Sciences

NEXT STORY
SpringWorks Therapeutics Announces Collaboration with Children’s Oncology Group to Conduct a Phase 2 Clinical Trial of Nirogacestat in Pediatric Patients with Desmoid Tumors and Reports Publication of Nirogacestat Case Series in Pediatric/Young Adult Desmoid Tumor Patients
PREV STORY
mHealth Apps Market size is projected to reach USD 57.57 billion with 21.1% CAGR till 2026; Driven by Increasing Investment in the Development of Newer Products, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RTI Surgical® Completes Acquisition of Paradigm Spine

author_avatar
NASDAQ Market News

BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering

author_avatar
NASDAQ Market News

Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS

author_avatar
NASDAQ Market News